Try to Continue Asenapine or Lumateperone on Admission

April 2020

Patients may be on new atypical antipsychotics...asenapine (Secuado, seh-KWAH-doh) or lumateperone (Caplyta, kah-PLY-tah).

There are now over a dozen of these second-generation options...with varying activity at receptors (dopamine, serotonin, etc). But efficacy seems similar.

If patients are on an asenapine patch or lumateperone at home for schizophrenia, try to continue it on admission.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Learn More

Already a subscriber? Log in

Not sold to individuals

Pumps Triage Smart Pump Questions
Med Safety Guide Safe Use of Ketamine
New Drugs Save the New Antibiotic Cefiderocol for Salvage Therapy
Pregnancy Put Macrolide Use During Pregnancy in Perspective
New Drugs Know How Bempedoic Acid Stacks Up to Other Non-Statins
Storage Disposal Educate Patients About How to Properly Dispose of Meds at Home
NSAIDs Be Ready to Answer Questions About OTC Diclofenac 1% Gel
Neurology Pain Don't Be Surprised to See Low-Dose Naltrexone on Home Med Lists
Antipsychotics Try to Continue Asenapine or Lumateperone on Admission

Try to Continue Asenapine or Lumateperone on Admission

Get unlimited access through an Enterprise license

Table of Contents